10x Genomics annual shares outstanding
2018
2019
2020
2021
2022
2023
2024
2025
10x Genomics Shares Outstanding History (TXG)
10x Genomics reported 127.7M shares outstanding at the end of fiscal 2025.
View full 10x Genomics company overview10x Genomics annual shares outstanding history
| Fiscal year | Period ended | Shares outstanding | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | 127.7M | 5.4M | +4.42% |
| 2024 | 2024-12-31 | 122.3M | 3.2M | +2.68% |
| 2023 | 2023-12-31 | 119.1M | 3.9M | +3.39% |
| 2022 | 2022-12-31 | 115.2M | 2.7M | +2.38% |
| 2021 | 2021-12-31 | 112.5M | 4.0M | +3.71% |
| 2020 | 2020-12-31 | 108.5M | 12.2M | +12.72% |
| 2019 | 2019-12-31 | 96.2M | 81.7M | +561.46% |
| 2018 | 2018-12-31 | 14.5M | — | — |
10x Genomics quarterly shares outstanding
Q4.18
Q3.19
Q4.19
Q1.20
Q2.20
Q3.20
Q4.20
Q1.21
Q4.21
Q4.22
Q4.23
Q4.24
Q4.25
| Fiscal quarter | Period ended | Shares outstanding | Change | YoY change |
|---|---|---|---|---|
| Q4 2025 | 2025-12-31 | 127.7M | 15.2M | +13.49% |
| Q4 2024 | 2024-12-31 | 122.3M | 12.7M | +11.59% |
| Q4 2023 | 2023-12-31 | 119.1M | 10.6M | +9.78% |
| Q4 2022 | 2022-12-31 | 115.2M | 9.6M | +9.09% |
| Q4 2021 | 2021-12-31 | 112.5M | 12.3M | +12.22% |
| Q1 2021 | 2021-03-31 | 109.6M | 11.4M | +11.66% |
| Q4 2020 | 2020-12-31 | 108.5M | 12.2M | +12.72% |
| Q3 2020 | 2020-09-30 | 105.6M | 9.5M | +9.86% |
| Q2 2020 | 2020-06-30 | 100.3M | 85.7M | +589.08% |
| Q1 2020 | 2020-03-31 | 98.1M | — | — |
| Q4 2019 | 2019-12-31 | 96.2M | — | — |
| Q3 2019 | 2019-09-30 | 96.1M | — | — |
| Q4 2018 | 2018-12-31 | 14.5M | — | — |
10x Genomics shares outstanding trends
Over the last five reported fiscal years, 10x Genomics's shares outstanding moved from 108.5M to 127.7M, a change of 19.2M. The latest reported quarter, Q4 2025, shows 127.7M.
About the metric
What shares outstanding means
Shares outstanding is the number of common shares held by investors at a reporting-period end. The count can change because of stock issuance, repurchases, conversions, acquisitions, or stock splits.
Calculation and source
SEC-reported period-end shares
TickerStat displays period-end common shares from SEC filings and adjusts older values to the current share basis when SEC-reported stock-split conversion ratios are available. Values remain as reported when no split ratio is available. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review 10x Genomics filings at SEC.gov ↗